Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab

Ian D. Pavord, Roland Buhl, Monica Kraft, Charlene M. Prazma, Robert G. Price, Peter H. Howarth, Steven W. Yancey

Source: ERJ Open Res, 8 (2) 00560-2021; 10.1183/23120541.00560-2021
Journal Issue: April

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ian D. Pavord, Roland Buhl, Monica Kraft, Charlene M. Prazma, Robert G. Price, Peter H. Howarth, Steven W. Yancey. Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab. ERJ Open Res, 8 (2) 00560-2021; 10.1183/23120541.00560-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.